Improved Buccal Delivery of Opioid Analgesics and Antagonists with Bitterless Prodrugs
- 1 January 1988
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 05 (9) , 615-618
- https://doi.org/10.1023/a:1015958417047
Abstract
Buccal delivery of opioid analgesics and antagonists is a useful way of improving bioavailability relative to the oral route. These compounds taste bitter, however. Various prodrugs of nalbuphine,...This publication has 13 references indexed in Scilit:
- Improvement of the Oral Bioavailability of Naltrexone in Dogs: A Prodrug ApproachJournal of Pharmaceutical Sciences, 1987
- Buccal morphine premedicationAnaesthesia, 1986
- Buccal and Oral Bioavailability of Nalbuphine in RatsJournal of Pharmaceutical Sciences, 1986
- Oral and rectal nalbuphine bioavailability: First‐pass metabolism in rats and dogsBiopharmaceutics & Drug Disposition, 1985
- BUCCAL MORPHINE—A NEW ROUTE FOR ANALGESIA?The Lancet, 1985
- Physical Model Approach to Taste Studies of Drugs and Pharmaceutical FormulationsJournal of Pharmaceutical Sciences, 1984
- Sublingual buprenorphine used postoperatively: ten hour plasma drug concentration analysis.British Journal of Clinical Pharmacology, 1982
- The systemic bioavailability of buprenorphine by various routes of administrationJournal of Pharmacy and Pharmacology, 1981
- Rationale for Design of Biologically Reversible Drug Derivatives: ProdrugsJournal of Pharmaceutical Sciences, 1975
- Chemical Modification of Clindamycin: Synthesis and Evaluation of Selected EstersJournal of Pharmaceutical Sciences, 1973